Ulrike Winkler Jenks

Array ( [id] => 6855694 [patent_doc_number] => 20030129195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Use of heat shock proteins' [patent_app_type] => new [patent_app_number] => 10/168901 [patent_app_country] => US [patent_app_date] => 2002-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13756 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20030129195.pdf [firstpage_image] =>[orig_patent_app_number] => 10168901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5985666 [patent_doc_number] => 20020098475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'Bovine immunodeficiency virus (BIV) based vectors' [patent_app_type] => new [patent_app_number] => 09/734836 [patent_app_country] => US [patent_app_date] => 2000-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17604 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20020098475.pdf [firstpage_image] =>[orig_patent_app_number] => 09734836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7064645 [patent_doc_number] => 20010043931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-22 [patent_title] => 'Human respiratory syncytial virus' [patent_app_type] => new [patent_app_number] => 09/730504 [patent_app_country] => US [patent_app_date] => 2000-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15583 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20010043931.pdf [firstpage_image] =>[orig_patent_app_number] => 09730504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1309548 [patent_doc_number] => 06613506 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-02 [patent_title] => 'Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes' [patent_app_type] => B1 [patent_app_number] => 09/724916 [patent_app_country] => US [patent_app_date] => 2000-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 35164 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/613/06613506.pdf [firstpage_image] =>[orig_patent_app_number] => 09724916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1534309 [patent_doc_number] => 06489122 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-03 [patent_title] => 'Method of detecting anti-Chlamydia pneumoniae antibody using Chlamydia pneumoniae-specific antigens' [patent_app_type] => B1 [patent_app_number] => 09/689913 [patent_app_country] => US [patent_app_date] => 2000-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33065 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/489/06489122.pdf [firstpage_image] =>[orig_patent_app_number] => 09689913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1499864 [patent_doc_number] => 06485914 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-26 [patent_title] => 'Method of detecting chlamydia pneumoniae gene using polynucleotides' [patent_app_type] => B1 [patent_app_number] => 09/689914 [patent_app_country] => US [patent_app_date] => 2000-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33052 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/485/06485914.pdf [firstpage_image] =>[orig_patent_app_number] => 09689914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1594032 [patent_doc_number] => 06491924 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-10 [patent_title] => 'Chlamydia pneumoniae antigenic polypeptide' [patent_app_type] => B1 [patent_app_number] => 09/689916 [patent_app_country] => US [patent_app_date] => 2000-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33053 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/491/06491924.pdf [firstpage_image] =>[orig_patent_app_number] => 09689916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 750693 [patent_doc_number] => 07022814 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-04-04 [patent_title] => 'Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses' [patent_app_type] => utility [patent_app_number] => 09/670105 [patent_app_country] => US [patent_app_date] => 2000-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7445 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 348 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/022/07022814.pdf [firstpage_image] =>[orig_patent_app_number] => 09670105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1317968 [patent_doc_number] => 06605460 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-12 [patent_title] => 'Avian pneumovirus vaccine' [patent_app_type] => B1 [patent_app_number] => 09/667976 [patent_app_country] => US [patent_app_date] => 2000-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6837 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/605/06605460.pdf [firstpage_image] =>[orig_patent_app_number] => 09667976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1357818 [patent_doc_number] => 06573091 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-03 [patent_title] => 'Chimeric viral packaging signal without gag gene sequences' [patent_app_type] => B1 [patent_app_number] => 09/554572 [patent_app_country] => US [patent_app_date] => 2000-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 18321 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/573/06573091.pdf [firstpage_image] =>[orig_patent_app_number] => 09554572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1115310 [patent_doc_number] => 06800463 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-05 [patent_title] => 'Method for mutation detection in HIV-1 using pol sequencing' [patent_app_type] => B1 [patent_app_number] => 09/640787 [patent_app_country] => US [patent_app_date] => 2000-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5165 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/800/06800463.pdf [firstpage_image] =>[orig_patent_app_number] => 09640787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1331757 [patent_doc_number] => 06596535 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-22 [patent_title] => 'Metabolically activated recombinant viral vectors and methods for the preparation and use' [patent_app_type] => B1 [patent_app_number] => 09/634126 [patent_app_country] => US [patent_app_date] => 2000-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 22 [patent_no_of_words] => 21700 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/596/06596535.pdf [firstpage_image] =>[orig_patent_app_number] => 09634126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1391991 [patent_doc_number] => 06537548 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-25 [patent_title] => 'Antibodies specific for ungulate PrP' [patent_app_type] => B1 [patent_app_number] => 09/627218 [patent_app_country] => US [patent_app_date] => 2000-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 13 [patent_no_of_words] => 19723 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/537/06537548.pdf [firstpage_image] =>[orig_patent_app_number] => 09627218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1395675 [patent_doc_number] => 06534066 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-18 [patent_title] => 'Inactivated vaccine against feline calicivirosis' [patent_app_type] => B1 [patent_app_number] => 09/616781 [patent_app_country] => US [patent_app_date] => 2000-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5945 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/534/06534066.pdf [firstpage_image] =>[orig_patent_app_number] => 09616781 [rel_patent_id] =>[rel_patent_doc_number] =>)